Genetic News and Research

RSS
New diagnostic platform simultaneously screens for all known pathogenic bacteria

New diagnostic platform simultaneously screens for all known pathogenic bacteria

New type of molecule shows early promise against treatment-resistant prostate cancer

New type of molecule shows early promise against treatment-resistant prostate cancer

Interweaving anxiety disorder associated with stuttering remains unrecognized

Interweaving anxiety disorder associated with stuttering remains unrecognized

Scientists discover primary, direct target of alcohol in the brain

Scientists discover primary, direct target of alcohol in the brain

Map of human liver cells reveals molecular make-up of individual cells

Map of human liver cells reveals molecular make-up of individual cells

New discovery may lead to better treatment options for pancreatic cancer patients

New discovery may lead to better treatment options for pancreatic cancer patients

Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer

Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer

Salk researchers advance sonogenetics technology for treating neurological conditions

Salk researchers advance sonogenetics technology for treating neurological conditions

Researchers identify common genetic connection in lung conditions

Researchers identify common genetic connection in lung conditions

Paternal exercise has significant impact on child's lifelong metabolic health

Paternal exercise has significant impact on child's lifelong metabolic health

Targeted drug and hormone therapy combination extends breast cancer survival

Targeted drug and hormone therapy combination extends breast cancer survival

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis

Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

Research provides insight into neurobiology of aggression and bullying

Research provides insight into neurobiology of aggression and bullying